IMA 'shocked' over Patanjali's claim on Coronil; demands explanation from Harsh Vardhan
Monday, 22 February 2021 () The IMA on Monday expressed shock over the "blatant lie of WHO certification" for Patanjali's Coronil tablet, which the company claims is an evidence-based medicine to fight Covid-19, and demanded an explanation from Union health ministerHarsh Vardhan in whose presence the medicine was launched. This comes in the wake of global health body, WHO, clarifying that it has not reviewed or certified the effectiveness of any traditional medicine for the treatment of Covid-19.
As Yog Guru Baba Ramdev launched "first evidence-based medicine for COVID-19 by Patanjali", Health Minister of India Dr Harsh Vardhan, who was present at the event, applauded traditional medicinal system, saying growth rate of Ayurveda's economy post-COVID rose to 50-90%. "Ayurveda has Rs 30,000...
People who are overweight and have diabetes are at a higher risk of developing the non-alcoholic fatty liver disease as the prevalence of NAFLD is around 9 percent to 32 percent in the Indian population, the Union Health Ministry informed on Monday. Researchers have found NAFLD in 40 to 80 per cent of people who have type-2 diabetes, and in 30 to 90 per cent of people who are obese. Studies also suggest that people with NAFLD have a greater chance of developing cardiovascular disease, a statement said. Launching the operational guidelines for Integration of NAFLD, Union Health Minister Dr Harsh Vardhan said, The Health Minister noted that India is becoming the first country in the world to identify the need for action for NAFLD. Meanwhile, the Central government said that the Ayushman Bharat program has so far screened 838.39 lakh people for hypertension, 683.34 lakh for diabetes and 806.4 lakh for the three common forms of cancer through Health and Wellness Centres (HWC). They have so far organised 6.91 lakh yoga and wellness sessions at the community level.
Yoga Guru Ramdev launched Patanjali's ‘Coronil’ to cure Covid-19 on Friday. Patanjali Ayurved said Coronil has got Ayush Ministry’s certification as per WHO scheme. The company claimed that it is the first evidence-based medicine to fight Covid-19. Ramdev also released research paper to back Patanjali's solutions to Covid-19. The ayurvedic medicine against coronavirus was launched at an event in New Delhi. The event was presided by Union Ministers Harsh Vardhan and Nitin Gadkari. Patanjali had earlier introduced Ayurveda-based Coronil on June 23 last year. The Haridwar-based firm, however, had to face criticism as it lacked scientific evidence. The Ayush Ministry, back then, had indicated it as 'Immuno-booster' only. Coronil is developed by Baba Ramdev's Patanjali Research Institute. It had started work for an Ayurvedic remedy for Covid-19 in January, 2020.
Credit: HT Digital Content Duration: 03:09Published
Yoga Guru Baba Ramdev has released research papers on Patanjali's Coronil medicine, the anti-Covid Ayurvedic drug that he first launched in June 2020. Ramdev had then claimed it was a 'medicine' however it was approved as an 'immunity booster' by the Centre.
#PatanjaliCoronil #Ramdev #Ayurveda
The first big real-world study of the Pfizer/BioNTech vaccine to be independently reviewed shows the shot is highly effective at preventing COVID-19, in a potentially landmark moment for countries desperate to end lockdowns and reopen economies. Gloria Tso reports.
New cases of the Buruli ulcer, a flesh-eating disease have been detected in parts of Australia mainly in the areas of Melbourne. Alarm has been raised after multiple cases have been identified in Australia. According to the World Health organization, ‘at least 33 countries with tropical, subtropical and temperate climates have reported buruli ulcer in Africa, South America, and Western Pacific regions.
#FleshEatingDisease #BuruliVirus #Pandemic
In an analysis, the Lancet COVID-19 Commission has called for three urgent actions in the COVID-19 response. "First, all regions with high rates of new COVID-19 cases, including the USA and the European Union (EU), should intensify measures to minimise community transmission and deploy COVID-19 vaccines rapidly," read the Lancet medical journal in its latest publication. Second, governments should urgently and fully fund WHO and the Access to COVID-19 Tools (ACT) Accelerator, including COVAX. Third, the G20 countries should empower the International Monetary Fund (IMF) and multilateral development banks to increase the scale of financing and debt relief. Success on all three priorities--containment of transmission, rapid vaccination, and emergency finance--will require improved global cooperation, it said. New lineages are increasing transmission of infection and raising risks in regions that have been less affected by COVID-19, including in sub-Saharan Africa. Additionally, acquired immunity from earlier COVID-19 infections might be less protective against reinfection with some of the new SARS-CoV-2 variants. Mutant lineages might also reduce the efficacy of COVID-19 vaccines and require adapted vaccines or boosters."* The medical journal also pointed out that at least half of the world's population lacks access to essential health services.
Yog Guru Ramdev on February 19 launched the "first evidence-based medicine for COVID-19 by Patanjali". During the event which saw presence of Union Health Minister Dr Harsh Vardhan and Union Minister..